ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Arterial occlusive disease | 24.04.02.021 | 0.000799% | | Not Available |
Effusion | 08.01.03.052 | - | - | Not Available |
Cerebral artery stenosis | 24.04.06.023; 17.08.02.010 | - | - | Not Available |
Blood count abnormal | 13.01.07.001 | 0.003197% | | Not Available |
Exfoliative rash | 23.03.07.006 | - | - | Not Available |
Pulmonary arterial hypertension | 22.06.01.002; 24.08.03.003 | 0.000208% | | Not Available |
Bone marrow failure | 01.03.03.005 | 0.001332% | | |
Cardiovascular insufficiency | 24.06.03.005; 02.01.01.011 | 0.000139% | | Not Available |
Cytopenia | 01.03.03.012 | 0.001865% | | Not Available |
Treatment failure | 08.06.01.017 | - | - | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | 0.001332% | | Not Available |
Acute kidney injury | 20.01.03.016 | 0.002398% | | |
Posterior reversible encephalopathy syndrome | 17.13.02.007 | 0.001332% | | |
Central nervous system haemorrhage | 17.08.01.035; 24.07.04.016 | 0.000139% | | Not Available |
Peripheral artery stenosis | 24.04.03.017 | 0.000799% | | Not Available |
Peripheral artery thrombosis | 24.01.02.010 | 0.000533% | | Not Available |
Aspergillus infection | 11.03.01.004 | 0.000208% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.000486% | | |
Liver function test increased | 13.03.01.044 | 0.000799% | | Not Available |
Full blood count decreased | 13.01.07.004 | 0.001066% | | Not Available |
Philadelphia chromosome positive | 13.22.02.003 | 0.000533% | | Not Available |
Pneumonia influenzal | 22.07.05.008; 11.05.03.003 | 0.000139% | | Not Available |
Terminal state | 08.01.03.079 | 0.000533% | | Not Available |
Blast crisis in myelogenous leukaemia | 16.01.08.002; 01.10.08.002 | 0.000695% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | 0.000799% | | Not Available |
Secondary immunodeficiency | 10.03.03.009 | 0.000533% | | Not Available |
Klebsiella infection | 11.02.03.003 | 0.000533% | | Not Available |
Leukaemia recurrent | 16.01.03.005; 01.10.03.005 | 0.000486% | | Not Available |
Acute lymphocytic leukaemia recurrent | 16.01.01.003; 01.10.01.003 | 0.001251% | | Not Available |
Graft versus host disease in skin | 23.07.04.025; 12.02.09.031; 10.02.01.062 | 0.001066% | | Not Available |